For Pharming as a global pharmaceutical company, ensuring patient safety is our number one goal, beyond mere compliance with worldwide regulations. By reporting adverse events for Pharming medicinal products, you help us to ensure the safety of our products. Your information will also enable Pharming to fulfill its reporting requirements to Health Authorities, which requires that Pharming provides information on adverse events with our products.
In case you experience or suspect any adverse event following the administration of our product(s), please contact Pharming via:
US and US territories:
Phone (Monday to Friday 6.00 a.m. to 4.00 pm): +1 (800) 930-5221
e-mail: safetyUS@pharming.com
Fax: +1 201-389-8092
You can also report (suspected) adverse events to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch
EU and Rest of World territories:
Phone (24/7 availability): +31 (0)71 5247 110
e-mail: safety@pharming.com
Fax: +31 (0)85 0643 382
All the information and personal data you share with us will be protected and kept confidential in line with our company standard operating procedures and applicable national and European data protection regulations. The information you provide will be used for the purpose of drug safety surveillance and to enable us to deal with your report appropriately. To understand how we collect and process your data when you submit an adverse event, please read our Privacy statement.
EU and Rest of World territories:
Phone (24/7 availability):
e-mail: safety@pharming.com
Fax: +31 (0)85 0643 382
US and US territories:
Phone (Monday to Friday 6.00 a.m. to 4.00 pm):
e-mail: safetyUS@pharming.com
Fax: +1 201-389-8092
You can also report (suspected) adverse events to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch
All the information and personal data you share with us will be protected and kept confidential in line with our company standard operating procedures and applicable national and European data protection regulations. The information you provide will be used for the purpose of drug safety surveillance and to enable us to deal with your report appropriately. To understand how we collect and process your data when you submit an adverse event, please read our Privacy statement.